dsm-firmenich launches Biond to advance biologics innovation
Specifically designed for cell culture media and biologics manufacturing, Biond™ helps biopharmaceutical companies optimize cell culture performance, improve process consistency, and maximize productivity throughout development and commercial manufacturing
19 Oct 2026
dsm-firmenich has launched Biond™, a dedicated portfolio of high-purity, pharmaceutical-grade vitamins for biopharmaceutical applications.
Biologics manufacturing depends on healthy, productive cells. Vitamins play a critical role in the metabolic pathways that drive cell growth, viability, and protein expression, making their purity, consistency, and reliability essential to process performance. To support these demanding applications, dsm-firmenich has developed Biond™.
Biond™ helps biopharmaceutical companies optimize cell culture performance, improve process consistency, and maximize productivity throughout development and commercial manufacturing.
Commercialized in partnership with Brenntag Pharma
dsm-firmenich’s Biond™ offering is available globally and exclusively through Brenntag’s biopharma product portfolio, BYPHAR*. The BYPHAR portal provides access to detailed product information, sample requests, and technical support via a trusted global biopharma distribution network.
“In biologics manufacturing, the performance of every raw material matters,” says Fernanda Onofre, Director, Global Marketing and Business Development — Pharma Biologics Solutions, dsm-firmenich.
“Vitamins are essential to healthy cell growth and productivity, so manufacturers need confidence in their purity, quality, and consistency. That’s why we go beyond ingredients. With Biond™, we’re bringing our pharmaceutical experience directly to biologics manufacturers, backed by our trusted partnership with Brenntag Pharma and its established biopharma distribution network. Together, we’re giving customers worldwide the quality, expertise, and support they need today, with a strong foundation for long-term success as biopharma continues to evolve.”
* Products made available through Biond™ and the BYPHAR portfolio are not marketed as active pharmaceutical ingredients (APIs) and are not intended to be used as APIs. They are intended exclusively as raw materials for biopharmaceutical applications outside the scope of ICH Q7.
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Tags
Frequently asked questions
Show frequently asked questions
How does Biond support cell culture media and biologics manufacturing?
Biond™ is dsm-firmenich’s portfolio of high-purity vitamins designed for cell culture media and biologics manufacturing. Its vitamins support metabolic pathways involved in cell growth, viability, and protein expression, helping biopharmaceutical companies improve process consistency and maximize productivity.
What expertise and supply capabilities support dsm-firmenich’s Biond portfolio?
Biond™ is backed by dsm-firmenich’s expertise in vitamin science, pharmaceutical-quality manufacturing, regulatory compliance, and sustainable production. A global manufacturing footprint and resilient supply network provide biologics manufacturers with quality assurance, technical expertise, and long-term supply reliability.
Where can biopharmaceutical companies access Biond vitamins and technical support?
Biond™ is available globally and exclusively through Brenntag Pharma’s BYPHAR biopharma product portfolio. The BYPHAR portal gives customers access to detailed Biond™ product information, sample requests, and technical support through Brenntag’s global biopharma distribution network.